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This opinion paper presents a short review of the potential impact of protein on muscle anabolism in
cancer, which is associated with better patient outcomes. Protein source is a topic of interest for patients
and clinicians, partly due to recent emphasis on the supposed non-beneficial effect of proteins; therefore,
misconceptions involving animal-based (e.g., meat, fish, dairy) and plant-based (e.g., legumes) proteins
in cancer are acknowledged and addressed. Although the optimal dietary amino acid composition to
support muscle health in cancer is yet to be established, animal-based proteins have a composition that
offers superior anabolic potential, compared to plant-derived proteins. Thus, animal-based foods should
represent the majority (i.e., 65%) of protein intake during active cancer treatment. A diet rich in plant-
derived proteins may support muscle anabolism in cancer, albeit requiring a larger quantity of protein to
fulfill the optimal amino acid intake. We caution that translating dietary recommendations for cancer
prevention to cancer treatment may be inadequate to support the pro-inflammatory and catabolic nature
of the disease. We further caution against initiating an exclusively plant-based (i.e., vegan) diet upon a
diagnosis of cancer, given the presence of elevated protein requirements and risk of inadequate protein
intake to support muscle anabolism. Amino acid combination and the long-term sustainability of a di-
etary pattern void of animal-based foods requires careful and laborious management of protein intake for
patients with cancer. Ultimately, a dietary amino acid composition that promotes muscle anabolism is
optimally obtained through combination of animal- and plant-based protein sources.
© 2021 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Research; CI, confidence interval; DIAAS, digestible indispensable amino acid score; MPB, muscle protein breakdown;
stibility corrected amino acid score; RDA, recommended dietary allowance; WCRF, World Cancer Research Fund.
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Cancer is a leading cause of mortality worldwide and is the main
cause of premature death in much of the Western Hemisphere and
Western Europe [1]. Early and continued optimization of nutri-
tional status, including elevated protein requirements [2,3], is
crucial to prevent and minimize negative health outcomes (e.g.,
muscle loss) often observed in cancer. Optimal nutrition is a hall-
mark of successful cancer treatment as it can alleviate symptom
burden, improve health and quality of life, and support survivor-
ship [4e7].
Many people with cancer recognize the importance of nutrition
and are often motivated to make lifestyle changes and improve
their dietary choices [8e10]. However, access to regulated nutrition
professionals in outpatient cancer centers is sparse, and only those
with, or at significant risk for, depleted nutritional status are likely
to be referred to a registered dietitian/nutritionist [11]. As such, the
burden to seek dietary advice is often placed on the patient.
Self-guided dietary changes, including restricting or eliminating
animal foods (e.g., meat and/or dairy) are common in cancer [9,12]
and often used by patients in an attempt to “cure the cancer” or
alleviate symptoms [13,14]. A Dutch study showed that people with
cancer (n ¼ 239) reported decreasing their meat intake and
increasing intake of plant-based foods following a cancer diagnosis
[15]. Similarly, a group of 1458 patients with stage I-IV colorectal
cancer reported several dietary changes, including decreased meat
and increased fruit, vegetables, fibers, wholegrains and fish con-
sumption [14]. Decreased meat intake (n ¼ 376) was more preva-
lent than increased fish consumption (n ¼ 342), although these
dietary changes were not quantified in relation to total protein
intake [14], and thus the effect of habitual dietary change on protein
intake was unclear. A study of the NutriNet-Sante cohort (n ¼ 696)
found that changes following a diagnosis of cancer included
decreased vegetable, dairy, meat, soy, and alcohol consumption
which cumulatively resulted in significantly lower total protein
intake (17.4 ± 12.5 g/day; p < 0.0001), compared with pre-
diagnosis [16]. Dietary changes post-diagnosis resulting in
decreased protein intake have also been observed in patients with
breast cancer [17]. Although some of these changes are beneficial to
overall health (e.g., decreased alcohol consumption), a diet con-
taining exclusively (i.e., vegan diet) or predominantly (i.e., vege-
tarian diet) plant-based foods is concerning due primarily to the
importance of animal-based protein for skeletal muscle health.
Acknowledging that healthy populations in the Americas,
Europe, and Oceania achieve much of their protein intake from
animal sources [18], the above-mentioned dietary changes should
not be overlooked, nor the consequences underestimated. Aside
from veganism, all diets contain a mixture of animal- and plant-
based proteins. Initiating a dietary pattern that restricts or elimi-
nates animal-based foods without careful consideration for
increased protein needs may hinder optimal nutritional status
following a diagnosis of cancer, especially related to the ability to
sustain muscle mass. Dietary proteins provide essential amino
acids required for muscle health. Muscle loss is a prominent
problem experienced by people with cancer despite the increasing
prevalence of obesity [19,20] and impacts prognosis and clinical
outcomes [21e23]. Loss of muscle is a defining feature of malnu-
trition, which has several consequences ranging from economic
[24] to physical burdens [23], and also of cancer cachexia, a debil-
itating multifactorial syndrome that results in functional debilita-
tion and mortality [25]. Muscle loss occurs to varying degrees
across stages and types of disease, body weight or weight stability/
change, and leads to detrimental clinical outcomes, including lower
tolerance to treatment and decreased survival [20e23,26]. In fact,
low muscle mass is emerging as a clinical marker of biological age,193the latter of which has been proposed as an important consider-
ation when prescribing anti-cancer therapies [27].
Given the importance of muscle health in the oncologic setting
and the notion that cancer is a catalyst for dietary change, we aimed
to address the potential impact of protein sources (i.e., animal- and
plant-based) onmuscle anabolism in cancer and suggest an optimal
ratio of intake. Herein, animal-based proteins include beef, pork,
chicken, fish, eggs, milk, cheese, etc. This opinion paper is a
narrative review and expert group understanding of available data.
Search term categories included ‘protein’, ‘muscle’, and ‘cancer’.
Key concepts are summarized in Box 1.
2. Protein intake and muscle mass
Whole-body skeletal muscle mass is dependent on rates of
muscle protein synthesis (MPS) and muscle protein breakdown
(MPB), collectively termed muscle protein turnover [28e30]. In a
healthy state, MPS and MPB are constantly changing in relation to
food intake to maintain muscle mass [30]. To achieve muscle
anabolism (i.e., growth), MPS on average must chronically exceed
MPB to obtain a positive net protein balance. The homeostatic state
of muscle protein turnover is disrupted in pro-inflammatory con-
ditions such as cancer [30,31]. Upregulation of ubiquitin-
proteasome/autophagy pathways [32] and a decline in MPS [33]
results in increased degradation of intracellular proteins and sub-
sequently loss of muscle mass [34]. Reduced protein intake because
of inflammation-related anorexia and the adverse effects of cancer
therapy further contribute to muscle loss [35,36]. In addition,
muscle protein synthesis is greatly affected by protein intake and
level of physical activity [29,37e40], which are often diminished in
cancer [41e43], further exacerbating catabolism.
The nutritional value of protein is determined by the quantity and
quality of constituent amino acids [44]. Amino acids are the dietary
anabolic drivers of muscle mass accretion but vary in quality and do
not equally promote anabolism [45,46]. The Protein Digestibility
CorrectedAminoAcidScore (PDCAAS) is indicativeof essential amino
acid content and digestibility of proteins [47]. Since the PDCAASwas
developed, another measure of protein quality was introduced: The
Digestible Indispensable Amino Acid Score (DIAAS) [48]. Notably,
these scores do not suggest true skeletalmuscle anabolic response to
a particular amino acid but do provide a proxy method of quality
comparison between proteins [28]. Dietary proteins have varying
amino acid profiles whereby animal-based proteins offer greater
anabolic stimuli when compared with plant-based alternatives
[28,49,50]. Plant-based proteins are less digestible (i.e., lower
PDCAAS) than animal-based proteins [47,51]. Other key differences
between animal and plant proteins are highlighted in Fig. 1.
Soy protein isolate (i.e., a purified form of soy) is the plant-based
protein that is an exception (high PDCAAS) as the absence of anti-
nutritional factors in the isolated form of soy increases the di-
gestibility of this product compared to soy protein in whole foods
[51,52]. As with whole foods, animal-based protein supplements
(e.g., whey) offer increased MPS and superior anabolic potential
compared with plant-based protein powders, including soy protein
isolate (PDCAAS 1.0) [28,53]. The decreased anabolic potential of
plant-proteins (including soy) may be due to increased amino acid
oxidation, decreased MPS, and lower leucine content compared to
animal proteins [49,53]. The presence of anti-nutritional factors
(e.g., trypsin inhibitors, tannins, phytates) may negatively impact
digestibility and availability of amino acids in plant-proteins [52].
Plant-based proteins resist proteolysis in the gastrointestinal tract
(i.e., decreasing their digestibility) due to their difference in struc-
ture when compared with animal-based proteins [54], which may
be especially concerning for people suffering from gastrointestinal
cancers (e.g., small bowel, pancreas, gastro-esophageal).
Box 1
Key Messages
 People with cancer need more protein than healthy
individuals.
 Animal proteins provide greater anabolic stimuli
compared with plant-based protein foods and are, there-
fore, better for muscle health.
 A combination of animal (65% of protein intake) and
plant proteins is likely to be optimal for supporting mus-
cle health and avoiding malnutrition during the treatment
of cancer.
 Eliminating animal proteins (i.e., vegan diet) is not a
recommended dietary change to pursue during active
treatment of cancer.
 During active treatment of cancer, the goals of nutritional
intake shift and do not necessarily parallel the recom-
mendations for cancer prevention and post-treatment.
 Theoretical arguments suggesting that nutrition feeds the
tumor are not supported by evidence and should not be a
reason to alter food choice.
 Individuals following well planned and balanced exclu-
sively (i.e., vegan) or predominantly (i.e., vegetarian)
plant-based diets for personal reasons (e.g., religious,
ethical) may be able to support muscle health during
treatment of cancer although a professional nutrition
assessment is highly recommended.
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protein isolate as most animal proteins (e.g., whey), the role of soy
for muscle health is a topic of interest [28,55]. Regardless, soy
protein appears to be inferior to animal-based proteins at stimu-
lating MPS and overall muscle anabolism in healthy older adults
[49,53]. Leucine is a key regulator [45] and possibly the sole stim-
ulator [56e59] of MPS. Leucine is also the most potent stimulator,
compared with other essential amino acids, of the mTOR pathway
e an essential anabolic pathway [46]. Animal-based proteins
generally contain more leucine than plant-based proteins except
for maize (corn), which in spite of its high leucine content is not a
complete protein [18]. The role of collagenous animal proteins in
muscle health has also been investigated. Collagen is an anomaly in
the context of animal-based proteins because it completely lacks
the essential amino acid tryptophan, rendering it incomplete and
thus having a DIAAS of 0 [51,60]. A review of the literature suggests
that MPS does not appear to be stimulated with collagen supple-
mentation [51] although acute experiments with collagen also are
difficult to interpret as tryptophan attached to albumin can
temporarily provide tryptophan [61]. Future research in this area is
needed; at this time, we do not recommend collagen supplemen-
tation for the specific purpose of muscle anabolism. Notably,
despite the potential role of specific protein sources or nutrients,
most dietary guidelines consider total protein intake rather than
the amino acid composition of dietary protein.Fig. 1. Visual comparison of select key nutritional differences between animal and
plant proteins. Legend: [: higher; Y: lower; 4: variable; Ø: none. Images retrieved
from smart.servier.com.3. Anabolic potential and protein source in cancer
The anabolic potential of skeletal muscle during cancer is
controversial; studies indicate both anabolic resistance [62,63] and
retained anabolic potential [19,62,64,65]. The etiology of cancer-
associated muscle loss is complex and not fully understood
despite its well-documented prevalence [20,63,64]. Cancer therapy
often includes surgery, which can have a drastic and negative194impact on skeletal muscle. The loss of muscle in the perioperative
period can stem from bedrest, the catabolic stress of the surgery
itself, and diminished nutritional intake [63]. A small study in pa-
tients with colorectal cancer found that compared to healthy
counterparts, those with cancer presented significantly less lean
mass (which includes muscle mass) in their lower extremities
before surgery [63]. Compared with the pre-operative period, those
undergoing tumor resection had further lower lean leg mass loss
post-operatively [63]. The benefits of nutrition therapy post-
operatively and upon discharge continue to be doubted despite
increasing acceptance of Enhanced Recovery After Surgery [66].
Although perioperative nutritional therapy alone may not alleviate
all nutritional challenges in patients undergoing surgery for cancer,
marginal gains achieved throughout the cancer trajectory have the
capacity to improve clinically relevant outcomes [66]. Hence, small
improvements in nutritional status should not be discounted if they
do not amount to clinically meaningful changes in isolation as the
additive effect of small improvements over time have the potential
to bring about clinically significant positive change [66].
Animal-based proteins are of major importance during the
active treatment of cancer to preclude detrimental loss of muscle
and promote muscle anabolism. Only a few amino acid kinetic
studies investigated whole-body protein synthesis and balance in
cancer over the last decade [62,67e69], as reviewed by Antoun &
Raynard [70]. Bozetti & Bozetti [71] previously reviewed the same
topic and cited studies that suggested increased [72e74] or
decreased/no change [73] in whole-body protein synthesis
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these studies forecast the effects of mimicking whole-food diets on
muscle change, translating results from amino acid kinetics to
whole-body anabolism is difficult, as whole-body protein turnover
does not necessarily equate to skeletal muscle protein anabolism
[70]. A study using a cachectic pig model that compared the effects
of a dairy with dairy/plant combination diet on skeletal muscle
anabolic response to feeding found that despite the diets having
equal leucine content, the dairy/plant diet was not effective in
inducing an anabolic response to feeding; in contrast, the whey
protein diet was [75]. A study investigating the effects of leucine on
tumor-bearing mice suggested that supplemental leucine may
protect muscle from disease-induced wasting [76], although to our
knowledge, a similar study is yet to be conducted in humans.
The role of the mTOR pathway inmediating amino acid-induced
skeletal muscle anabolism is well-established. Nevertheless, the
mTORC1 pathway is also involved in negative forms of anabolism,
including tumor growth, such that some fear nutritionally-derived
anabolic stimuli (e.g., protein) may also fuel or be associated with
tumor growth [77]. Despite amino acids having heterogeneous ef-
fects on tumor growth in humans, the effect of protein intake on
tumor growth has not been substantiated [78]. In general, inter-
national guidelines on nutrition in cancer acknowledge that theo-
retical arguments suggesting that nutrition feeds the tumor are not
supported by evidence and should not be a reason to alter nutrition
delivery [2].
4. Protein in nutrition oncology guidelines (during curative
or palliative cancer treatment)
Protein intake in cancer is highly variable, and many patients do
not meet the minimum recommended intake [41,42,79,80]. Nutri-
tional oncology guidelines recommend a minimum intake of 1.0 g
protein/kg body weight/d but suggest a target consumption of
1.2e2.0 g/kg/d [2]. These guidelines are similar to those for older
adults, which recommend at least 1.0e1.2 g/kg/d, acknowledging
that those with acute or chronic illness require more protein
(1.2e1.5 g/kg/d) [81]. Given that targeting guideline-based protein
levels with individualized nutrition support improves clinical out-
comes in cancer [7] and that increased total protein intake in adults
over the age of 65 years (similar to the median age of a cancer
diagnosis) has a protective effect [82], it appears that total protein
intake should be a co-primary consideration in addition to protein
quality. Notably, historical concerns regarding the supposed nega-
tive impact of protein on kidney health are unfounded. Higher
protein intakes (2.0 g/kg/d) are safe for people with healthy
kidney function [2,44] and may reduce mortality in critically ill
patients [83], although those with pre-existing kidney disease
should maintain a lower intake [84,85].
Protein intake recommendations in cancer are notably higher
than the recommended dietary allowance (RDA) of 0.8 g/kg/d for
the healthy population, determined by nitrogen balance studies
[86]. These studies primarily used high-quality proteins with a
PDCAAS of 1.0 (e.g., animal-based proteins or soy protein isolate)
[28,86e88]. Based on the methodology used to determine the RDA,
this value should be considered a minimum amount needed to
attain nitrogen balance rather than an amount sufficient to pro-
mote muscle maintenance or anabolism [44]. Conversely, the rec-
ommendations for patients with cancer are primarily based on
expert opinions given the paucity of studies that investigated ni-
trogen balance or the impact of protein intake on clinical outcomes
[2]. As oncology recommendations were derived from protein
metabolism studies [2,62,89,90], the guidelines also acknowledge
that the optimal amino acid composition for patients with cancer
remains unknown [2].195The risk of malnutrition varies in people with cancer [91],
especially between the curative and palliative setting, although the
potential benefit of animal protein is present given the association
of low muscle mass with malnutrition [23]. Studies employing
isotopic tracer methods are needed to determine specific amino
acid requirements in oncology settings [92]; for example, the in-
dicator amino acid oxidationmethod is one technique that could be
used to determine total protein requirements in a non-invasive
manner [93]. Additionally, challenges of understanding optimal
protein quantity and amino acid composition for muscle mass
maintenance or anabolism are compounded by gut dysfunction,
which is observed in patients with cancer, resulting in decreased
protein digestion of oral food intake and absorption [94,95]. The
reduction in protein digestion negatively impacts systemic amino
acid availability and leads to increased quantity of undigested
proteins in the colon [94,95]. The latter can alter microbial meta-
bolism and generate harmful metabolites which may negatively
affect muscle health [94,95].
5. Additional considerations and current evidence of animal-
and plant-based protein intake during cancer treatment
One of the ten World Cancer Research Fund and the American
Institute for Cancer Research (WCRF/AICR) recommendations for
prevention of cancer is to follow the remaining nine recommen-
dations for those diagnosed with cancer [96]. Translating dietary
recommendations for prevention of cancer to patients with active
cancer may provide insufficient nutritional targets and, therefore,
suboptimal nutritional status. Some dietary strategies for preven-
tion of cancer might result in worse outcomes once a diagnosis of
cancer is made. Although controversial, red meat may be positively
associated with the incidence of colon cancer, although the asso-
ciation may be inversely related to colon cancer mortality [97]. In a
cohort of 992 patients with stage III colon cancer, restricted red and
processed meat intake was associated with increased risk of death
[97]. Additionally, diet quality was not associated with overall
survival in a cohort of 1284 patients with metastatic colorectal
cancer [98].We propose that once a diagnosis of cancer is made, the
goals of nutritional intake shift and do not necessarily parallel the
recommendations for cancer prevention and post-treatment
(survivors).
When considering protein sources, one concern regarding an
exclusively, or even predominantly, plant-based diet during active
treatment of cancer is the feasibility of obtaining adequate dietary
amino acid intake to sustain functional muscle reserves, especially
given the high risk of malnutrition in this population [91] (Fig. 3).
Cancer therapy is frequently accompanied by nutrition-impact
symptoms (e.g., nausea, anorexia, taste alterations) that can affect
food intake and compound muscle catabolism [99,100]. Early sati-
ation can also contribute to decreased oral intake and may be
influenced by nutrients in the diet (e.g., protein, fiber). As discussed,
protein intake is essential for muscle health in cancer, although
caloric intake is also vital for optimizing nutrition in this vulnerable
population. In older adults, essential amino acid supplementation
has been proposed as a complementary measure, in addition to
protein intake, that does not impact satiety, optimizes the ability to
meet nutritional requirements, and promotes muscle health [101].
The efficacy of essential amino acid supplementation requires
further investigation in clinical settings, including cancer. Similarly,
although the satiating effect of protein has been studied in other
populations, how a predominantly plant-vs. animal-based diet af-
fects satiety is unknown in people with cancer or at risk of
malnutrition [102]. Regardless of satiating effects, a larger volume
of plant-based proteins than animal-based products is required to
obtain adequate amino acid intake [103]. It follows that the higher
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from a smaller volume of food [28], as shown in Fig. 2.
Despite some insight into protein intake in this population,
studies investigating protein quality or types of protein consumed
are lacking [2]. In healthy middle-aged women, those consuming
~68% of their protein from animal sources (animal:plant protein
intake ratio 2.09) had significantly higher muscle mass compared
with vegetarians consuming ~55% of their protein from animal
sources (animal:plant protein intake ratio 1.23) [104]. Given the
paucity of research on optimal ratio of protein sources in cancer,
interpretations can be drawn from studies in populations at similar
risk of malnutrition as those undergoing treatment of cancer to
provide insight and a starting point into appropriate nutrition
needed to optimize health in cancer. In older adults with comor-
bidities, at least 65% of protein intake from high-quality protein
(i.e., animal-based protein) is needed to avoid malnutrition [105].
Additionally, factors similar to those seen in people undergoing
treatment of cancer (e.g., missing a meal, taste alterations) were
independently associated with inadequate intake of 1 essential
amino acid and subsequently greater risk of malnutrition [105].
Given the paucity of this type of research in cancer and the simi-
larity in malnutrition risk and nutrition impact symptoms between
populations, we propose that inferences be drawn and a minimum
of 65% of protein intake from animal sources be considered as an
optimal starting point to support muscle anabolism for people
undergoing active cancer treatment. Future trials should seek to
determine the optimal animal:plant protein ratio to supportmuscle
mass in cancer.
Ongoing trials are investigating protein needs [106] and the
clinical impact of increased protein [107,108] or amino acid
[109,110] intake on muscle in people with cancer. The impact ofFig. 2. Select nutritional differences between animal and plant proteins are highlighted with
Plant proteins include beans, lentils, soy, nuts, etc. Legend: [: higher; Y: lower; 4: variable
beef e 6112; beans e 7085.
196protein on muscle strength is also an important consideration in
cancer given that muscle weakness can occur without loss of
muscle mass [31]. A review that focused on nutritional in-
terventions for muscle strength in cancer found no studies that
compared plant-with animal-based diet interventions [111]. Clin-
ical trials related to protein source and muscle anabolism in cancer
primarily focused on MPS and MPB rather than whole-body lean
mass response and its impact on clinical outcomes. A paradox exists
in current research whereby humans consume predominately
whole foods, yet research has focused on specific amino acids and
their contribution to muscle protein turnover. Pragmatic studies
employing a whole-food approach exploring the influence of pro-
tein sources on whole-body skeletal muscle anabolism are needed
to guide future nutrition recommendations.
It is our opinion that in catabolic disease states such as cancer,
the attributes of animal-based proteins contribute to optimal
nutrition care and can be safely included in the diet. We
acknowledge various reasons (ethical, religious, planetary, health,
etc.) for choosing a plant-based diet. Those already consuming a
balanced exclusively or predominantly plant-based diet may ach-
ieve adequate nutritional intake to support health, although
appropriate knowledge of diet diversity is needed to ensure higher
protein needs are met [112,113]. Initiating an unbalanced exclu-
sively or predominantly plant-based dietary pattern during active
treatment of cancer may impact negatively on the ability to achieve
optimal protein intake. In contrast, a dietary pattern that combines
protein from animal- and plant-based sources is, in our view, more
likely to be the most suitable option for optimal health.
Lastly, although not the focus of this paper, and regardless of
protein sources in the diet, exercise is a viable proponent of a
multimodal approach to supporting muscle health in cancer. It isfood examples. Animal proteins include beef, pork, chicken, fish, eggs, milk, cheese, etc.
; Ø: none. Images retrieved from smart.servier.com. Canadian Nutrient File food codes:
Fig. 3. Flowchart of important nutrition-related considerations based on health status. Legend: [: increased; Y: decreased; 4: neutral; animal proteins: beef, pork, chicken, fish,
eggs, milk, cheese, etc.; plant proteins: beans, lentils, soy, nuts, etc. Images retrieved from smart.servier.com.
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role of resistance exercise and nutrition to mitigate muscle loss in
pro-catabolic states has been extensively reviewed, emphasizing
the importance of a multimodal approach to muscle health
[115e117].
6. Dietary guidelines for healthy populations (for cancer
prevention and post-treatment)
National dietary guidelines for healthy populations (including
prevention of cancer and post-treatment) have increasingly
emphasized plant-based foods for overall health, chronic disease
prevention, and sustainability [118e121]. The WCRF/AICR has ten
recommendations related to diet, nutrition, and physical activity
for prevention of cancer. In line with select national dietary
guidelines worldwide, the WCRF/AICR recommends limiting con-
sumption of red and processed meat [96]. Although guidelines
explicitly state not to avoid meat consumption entirely, the
layperson may be inclined to adopt an exclusively or predomi-
nantly plant-based diet based on recommendations for cancer
prevention. A review of the literature could not confirm that
substituting animal-based proteins with plant-based options
reduced the risk of developing cancer [122]. The limited and con-
flicting evidence of protein sources challenges the ability to draw
confident conclusions; thus, the positive and negatives effects of
these types of foods must beweighed in relation to health priorities
[123e126]. Elimination of specific foods or food groups without197supportive substitution is concerning as nutritional considerations
of dietary intake are complex and should not be dichotomized as
‘good’ or ‘bad’. Protein needs for prevention of cancer and post-
cancer treatment may not be elevated compared with protein
needs during active cancer treatment, therefore the former can
likely be reasonably achieved with predominantly plant-based
foods given the lower risk for malnutrition and muscle loss in
this population (Fig. 3). Thus, obtaining 65% of protein from ani-
mal sources may not be essential to sustain muscle mass in this
healthy population. In general, protein intake from animal- and
plant-based sources is highly variable. One study in healthy adults
found that self-reported vegetarians (n ¼ 2370) consumed 50.9% of
their protein (g) from animal sources, whereas meat eaters
(n ¼ 90,664) ingested 70.8% of protein from animal sources [127].
Regardless of self-reported diet strategies, the definition of a pre-
dominantly plant-based diet remains controversial, compounding
the challenge of determining optimal ratios of protein intake based
on nutritional needs.
An important consideration is that the response of skeletal
muscle to dietary anabolic stimuli may be blunted with age and,
thus, older adults may have increased protein needs [81]. Moreover,
increased protein intake is protective against mortality in adults
over the age of 65 years [82]. Additional considerations for older
adults with cancer include age-associated changes in appetite
regulation, lack of hunger, a decline in taste and smell, reduced
central and peripheral drive to eat, delayed gastric emptying and
deteriorating dentition [128]. These are why animal protein intake
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intake in older adults may be compromised [49].
7. General benefits of plant-based proteins
Dietary guidelines for chronic disease prevention do not account
for the source of protein, despite its importance given the diverse
protein intake patterns observed worldwide [18]. As illustrated in
Figs. 1 and 2, plant-based proteins are higher in essential fatty acids
and fiber, whereas they are lower in protein, essential amino acids,
and certain micronutrients (e.g., iron, vitamin B12, zinc) [129].
Globally, plant-based options are the predominant source of
protein [18,49]. Compared with animal counterparts, plant-based
proteins are more environmentally sustainable, requiring fewer
resources (e.g., land and water) and producing lower levels of
greenhouse-gas emissions [119,130]. As such, many people are
adopting an exclusively or predominantly plant-based diet,
regardless of health status [119,131]. For example, national and
international oncology groups support incorporating soy-based
foods as a part of a healthy diet for prevention of cancer and dur-
ing active treatment [132,133]. The high isoflavone content of soy
continues to foster unfounded concerns regarding a potential link
between soy intake and negative health outcomes relating to hor-
mone production [122,132,134]. Soy intake has not been linked to
cancer occurrence or recurrence; conversely, the isoflavones have
anti-inflammatory properties that may decrease the risk of cancer
occurrence [122,135].
In the absence of disease, it is possible to maintain a healthy diet
without consuming animal products if eliminating the latter is
substituted with alternatives that contain adequate essential nu-
trients [136]. Importantly, a regulated health care professional who
is a nutrition expert (e.g., registered dietitian/nutritionist) should
be consulted before making any drastic dietary changes. These
professionals can counsel patients and provide strategies to achieve
adequate intake, especially those who are already following an
exclusively or predominantly plant-based diet while undergoing
oncologic treatment.
8. Conclusion
We argue that the inclusion of anabolic-stimulating animal
proteins like beef, pork, chicken, fish, eggs, milk, cheese, etc. is key
to achieving clinical benefits related to muscle anabolism in cancer,
especially given the higher protein needs due to the pro-
inflammatory nature of the disease, low intake levels, and decon-
ditioning of these patients. Drastic changes to food choice such as
eliminating animal products from the diet may negatively interfere
with the quality and quantity of protein intake if not properly
substituted in the diet and do not align with international nutri-
tional oncology guidelines. Without adequate substitution with
other foods, nutritional status may be compromised if meat-
derived proteins are reduced or eliminated. We support the
increased incorporation of plant-based proteins. However, we
caution that a dichotomous approach to eating that eliminates
animal products may lead to inferior anabolic stimuli and greater
quantity and variability of protein sources needed to achieve
skeletal muscle anabolism, especially once diagnosed with cancer.
Thus, we propose that in the oncologic setting, a minimum of 65%
of protein intake should be derived from animal sources as an initial
starting point although further research in this area is needed.
Following successful cancer treatment, increased consumption of
plant-based proteins may be adequate to sustain muscle health but
requires careful planning if substituting animal products in the diet.
Dietary changes can be optimized with the help of a registered
dietitian/nutritionist.198Funding statement
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